Research and Development

Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.

Category:

Random Site Quote:

2009-Jul-23 | miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics 2009-Jul-21 | Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics... 2009-May-06 | Archemix Appoints Ken Bate as President and Chief Executive Officer... Archemix
For detailed information visit the website, please...

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

2. Arena Pharmaceuticals, Inc.

Receptor-based drug discovery in the fields of diabetes, obesity, cardiovascular, sleep disorders, neurodegeneration, schizophrenia, depression and anxiety. Profile of company in San Diego, California. (Nasdaq: ARNA)

Category:

Random Site Quote:

Lorcaserin Published in New England Journal of Medicine The lorcaserin Phase 3 BLOOM trial was published in the New England Journal of Medicine. Lorcaserin for Weight Management Our most advanced drug candidate, lorcaserin, is for weight management, including weight loss and maintenance of
For detailed information visit the website, please...

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

3. AVI Biopharma, Inc.

Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII)

Category:

Random Site Quote:

As global leaders in the field of RNA-based therapeutics, we are aggressively leveraging our differentiated and proprietary RNA-based antisense platforms to discover and advance innovative therapeutic candidates. We are committed to the discovery and development of novel RNA-based therapeutics
For detailed information visit the website, please...

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

4. Avigen, Inc.

Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)

Category:

Random Site Quote:

For detailed information visit the website, please...
waiting for hand_moderation

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

5. EntreMed, Inc.

Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD)

Category:

Random Site Quote:

EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases. EntreMed's drug candidates target disease cells and the blood vessels that nourish them. The Company's goal is to
For detailed information visit the website, please...

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

6. BioSphings AG.

Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany.

Category:

Random Site Quote:

BioSphings, a biopharmaceutical company based in Frankfurt, Germany, focuses on the development of novel therapeutic approaches for the treatment of cancer, autoimmune diseases and viral infections.
BioSphings Aktiengesellschaft BioSphings, a biopharmaceutical company based in Frankfurt, Germany, focuses on the development of novel therapeutic approaches for the treatment of cancer, autoimmune diseases and viral infections. The privately held company owns a of protected drug candidates which

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

7. Curis, Inc

Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)

Category:

Random Site Quote:

This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Curis' future financial position, business strategy and plans and objectives of management for future operations. We may use such words as
For detailed information visit the website, please...

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

8. Cyano Biotech GmbH.

Identifies and characterises structural variants of polyketides and non-ribosomal cyclic heptapeptides from cyanobacteria, and optimises pharmacological activity using biocombinatorial techniques. Profile, collaborators and contacts in Germany.

Category:

Random Site Quote:

Cyano Biotech identifies and characterises natural products by screening cyanobacteria and optimises bioactive compounds regarding harmacological needs employing combinatorial biosynthesis generating novel lead compounds for the pharma industry.

For detailed information visit the website, please...

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

9. Genelabs Technologies, Inc.

Discovers, develops and commercializes therapies for systemic lupus erythematosus, viral diseases and cancer. Located in Redwood City, California.(Nasdaq: GNLB)

Category:

Random Site Quote:

For detailed information visit the website, please...
waiting for hand_moderation

Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0

Member Reviews

Visitor Ratings

Google PR

10. Genentech, Inc.

Development, production, and marketing of human therapeutics. Includes research history, product pipeline, global corporate and career information. San Francisco, California.

Category: